Radiosensitization with low-dose carboplatin enhances pain palliation in radioisotope therapy with strontium-89

Nuclear Medicine Communications

Volumn 17, Issue 9, 1996, Pages 799-804

  Sciuto, R ^a   Maini, Carlo L ^a   Tofani, A ^a   Fiumara, C ^a   Scelsa, M G ^a   Broccatelli, M ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; STRONTIUM 89;

ADULT; AGED; ANALGESIA; ARTICLE; BONE METASTASIS; CANCER PALLIATIVE THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; RADIOISOTOPE THERAPY; RADIOSENSITIZATION;

EID: 0029785223     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199609000-00011     Document Type: Article

References (20)

1. Pecher C. Biological investigations with radioactive calcium and strontium: Preliminary report on the use of radioactive strontium in the treatment of metastatic bone cancer. Univ Calif Publ Pharmacol 1942; 11: 117-149.
2. Lawrence JH, Wassermann LR. Multiple myeloma: A study of 24 patients treated with radioactive isotopes (32P and 89Sr). Ann Intern Med 1950; 33: 41-55.
3. Kloiber R, Molnar C, Barnes M. Sr-89 therapy for metastatic bone disease: Scintigraphic and radiographic follow-up. Radiology 1987; 163: 719-723.
4. Robinson RG, Spicer JA, Preston DF et al Treatment of metastatic bone pain with strontium-89. Nucl Med Biol 1987; 14: 219-222.
5. Tennvall J, Darte L, Lundgren R et al Palliation of multiple bone métastasés from prostatic carcinoma with strontium-89. Acta Oncol 1988; 27: 365-369.
6. Robinson RG, Spicer JA, Blake GM et al. Strontium-89 treatment results and kinetics in patients with painful metastatic prostate and breast cancer in bone. Radiographies 1989; 9: 271-281.
7. Laing AH, Ackery DM, Bayly RJ et al. Strontium-89 chloride for pain palliation in prostatic skeletal malignancy. Br J Radiol 1991; 64: 816-822.
8. Lewington VJ, McEwan AJ, Ackery DM et al. A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone. Eur J Cancer 1991; 27: 954-958.
9. Porter AT, McEwan AJ, Powe JE et al. Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer. Int J Radiat Oncol Biol Phys 1992; 25: 805-813.
10. Mertens WC, Porter AT, Reid RH et al. Strontium-89 and low-dose infusion cisplatin for patients with hormone refractory prostate carcinoma metastatic to bone: A preliminary report. J Nucl Med 1992; 33: 1437-1443.
11. Soloway MS, Hardeman SW, Hickey D et al. Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan. Cancer 1988; 61: 195-202.
12. Hartigan JA. Clustering algorithms. New York: John Wiley, 1975.
13. Galasko CSB, Bennet A. Relationship of bone destruction in skeletal métastasés to osteoclast activation and prostaglandins. Nature 1976; 263: 508-510.
14. Richmond RC, Powers EL. Radiation sensitization of bacterial spores by cis-dichlorodiamineplatinum (II). Radiat Res 1976; 68: 20-23.
15. Fu KK. Biological basis for the interaction of chemotherapeutic agents and radiation therapy. Cancer 1985; 55: 2123-2130.
16. Fu KK, Lam KN, Rayner PA. Effects of continuous low dose rate irradiation and concurrent infusion of mitomycin, cisplatin and 5-fluorouracil on three mouse tumours. Endocrine Hypertherm Oncol 1986; 2: 157-162.
17. Begg AC. Cisplatin and radiation: Interaction probabilities and therapeutic possibilities. Int J Radiat Oncol Biol Phys 1990; 19: 1183-1189.
18. Richmond RC, Simic MG. Effect of radiation on cis-di-chlorodiamineplatinum (II) and DNA in aqueous solution. Br J Cancer 1978; 37 (suppl. 3): 20-23.
19. Calvert AH, Harland SJ, Harrap KR et al. JM8 development and clinical projects. In: Hacker MP, Douple EB, Krakoff IH, eds. Platinum coordination complexes in cancer chemotherapy. Boston, MA: Martinus Nijhoff, 1984: 240-252.
20. Tothill P, Klys HS, Matheson LM et al The long-term retention of platinum in human tissues following the administration of cisplatin or carboplatin for cancer chemotherapy. Eur J Cancer 1992; 28: 1358-1361.